E71.51

The ICD-10-CM code for disorders of peroxisome biogenesis is E71.51. The full clinical description is "Disorders of peroxisome biogenesis". E71.51 is a non-billable header code. Use a more specific child code for billing purposes.

ICD-10-CM code E71.51 represents “Disorders of peroxisome biogenesis”. It is classified under Chapter 4: Endocrine, Nutritional and Metabolic Diseases and is a non-billable header code. Use a more specific child code for billing purposes.

No, E71.51 is a non-billable header code. You need to use one of its more specific child codes for billing. There are 3 child codes under E71.51.

E71.51 is in Chapter 4: Endocrine, Nutritional and Metabolic Diseases (codes E00-E89).

E71.51 has Excludes1 notes indicating codes that cannot be used together with it, including: transitory endocrine and metabolic disorders specific to newborn (P70-P74); androgen insensitivity syndrome (E34.5-); congenital adrenal hyperplasia (E25.0); and 5 more.

E71.51 has 3 child codes, including: E71.510 (Zellweger syndrome), E71.511 (Neonatal adrenoleukodystrophy), E71.518 (Other disorders of peroxisome biogenesis).

E71.51 is linked to 2 UMLS Concept Unique Identifiers: C1832200, C2874247. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.

ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like disorders of peroxisome biogenesis affect a person's functioning: body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.

There is no direct ICD-11 mapping available for E71.51 in the WHO crosswalk tables. This may mean the concept is classified differently in ICD-11. Use the ICD-10 to ICD-11 converter to search for related codes.